216 related articles for article (PubMed ID: 35275559)
1. Cardiac Alpha-Synuclein Is Present in Alpha-Synucleinopathies.
Javanshiri K; Drakenberg T; Haglund M; Englund E
J Parkinsons Dis; 2022; 12(4):1125-1131. PubMed ID: 35275559
[TBL] [Abstract][Full Text] [Related]
2. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
[TBL] [Abstract][Full Text] [Related]
3. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
Spillantini MG; Goedert M
Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
[TBL] [Abstract][Full Text] [Related]
4. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.
Peelaerts W; Bousset L; Van der Perren A; Moskalyuk A; Pulizzi R; Giugliano M; Van den Haute C; Melki R; Baekelandt V
Nature; 2015 Jun; 522(7556):340-4. PubMed ID: 26061766
[TBL] [Abstract][Full Text] [Related]
5. Sudden cardiac death in synucleinopathies.
Javanshiri K; Drakenberg T; Haglund M; Englund E
J Neuropathol Exp Neurol; 2023 Feb; 82(3):242-249. PubMed ID: 36668680
[TBL] [Abstract][Full Text] [Related]
6. Selective vulnerability in α-synucleinopathies.
Alegre-Abarrategui J; Brimblecombe KR; Roberts RF; Velentza-Almpani E; Tilley BS; Bengoa-Vergniory N; Proukakis C
Acta Neuropathol; 2019 Nov; 138(5):681-704. PubMed ID: 31006067
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease.
Reyes JF; Ekmark-Léwen S; Perdiki M; Klingstedt T; Hoffmann A; Wiechec E; Nilsson P; Nilsson KPR; Alafuzoff I; Ingelsson M; Hallbeck M
Acta Neuropathol Commun; 2021 Mar; 9(1):46. PubMed ID: 33743820
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
Giannoccaro MP; Donadio V; Giannini G; Devigili G; Rizzo G; Incensi A; Cason E; Calandra-Buonaura G; Eleopra R; Cortelli P; Liguori R
Parkinsonism Relat Disord; 2020 Dec; 81():48-53. PubMed ID: 33049589
[TBL] [Abstract][Full Text] [Related]
9. Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy.
Nimmo JT; Verma A; Dodart JC; Wang CY; Savistchenko J; Melki R; Carare RO; Nicoll JAR
Alzheimers Res Ther; 2020 Nov; 12(1):159. PubMed ID: 33256825
[TBL] [Abstract][Full Text] [Related]
10. Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential.
Ferreira N; Gram H; Sorrentino ZA; Gregersen E; Schmidt SI; Reimer L; Betzer C; Perez-Gozalbo C; Beltoja M; Nagaraj M; Wang J; Nowak JS; Dong M; Willén K; Cholak E; Bjerregaard-Andersen K; Mendez N; Rabadia P; Shahnawaz M; Soto C; Otzen DE; Akbey Ü; Meyer M; Giasson BI; Romero-Ramos M; Jensen PH
Acta Neuropathol; 2021 Jul; 142(1):87-115. PubMed ID: 33978813
[TBL] [Abstract][Full Text] [Related]
11. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
[TBL] [Abstract][Full Text] [Related]
12. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
[TBL] [Abstract][Full Text] [Related]
13. ɑ-Synuclein strains and the variable pathologies of synucleinopathies.
Peelaerts W; Baekelandt V
J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014
[TBL] [Abstract][Full Text] [Related]
14. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
[TBL] [Abstract][Full Text] [Related]
15. Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.
Rey NL; George S; Brundin P
Neuropathol Appl Neurobiol; 2016 Feb; 42(1):51-76. PubMed ID: 26666838
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward.
Bellomo G; De Luca CMG; Paoletti FP; Gaetani L; Moda F; Parnetti L
Neurology; 2022 Aug; 99(5):195-205. PubMed ID: 35914941
[TBL] [Abstract][Full Text] [Related]
17. Skin α-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study.
Donadio V; Incensi A; El-Agnaf O; Rizzo G; Vaikath N; Del Sorbo F; Scaglione C; Capellari S; Elia A; Stanzani Maserati M; Pantieri R; Liguori R
Sci Rep; 2018 Sep; 8(1):14246. PubMed ID: 30250046
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Orimo S
Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein Conformational Strains as Drivers of Phenotypic Heterogeneity in Neurodegenerative Diseases.
So RWL; Watts JC
J Mol Biol; 2023 Jun; 435(12):168011. PubMed ID: 36792008
[TBL] [Abstract][Full Text] [Related]
20. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
